These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. NF1 mutation-driven neuronal hyperexcitability sets a threshold for tumorigenesis and therapeutic targeting of murine optic glioma. Anastasaki C; Chatterjee J; Koleske JP; Gao Y; Bozeman SL; Kernan CM; Marco Y Marquez LI; Chen JK; Kelly CE; Blair CJ; Dietzen DJ; Kesterson RA; Gutmann DH Neuro Oncol; 2024 Aug; 26(8):1496-1508. PubMed ID: 38607967 [TBL] [Abstract][Full Text] [Related]
7. Athymic mice reveal a requirement for T-cell-microglia interactions in establishing a microenvironment supportive of Pan Y; Xiong M; Chen R; Ma Y; Corman C; Maricos M; Kindler U; Semtner M; Chen YH; Dahiya S; Gutmann DH Genes Dev; 2018 Apr; 32(7-8):491-496. PubMed ID: 29632086 [TBL] [Abstract][Full Text] [Related]
8. Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth. Simmons GW; Pong WW; Emnett RJ; White CR; Gianino SM; Rodriguez FJ; Gutmann DH J Neuropathol Exp Neurol; 2011 Jan; 70(1):51-62. PubMed ID: 21157378 [TBL] [Abstract][Full Text] [Related]
9. Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival. Pan Y; Smithson LJ; Ma Y; Hambardzumyan D; Gutmann DH Oncotarget; 2017 May; 8(20):32977-32989. PubMed ID: 28380429 [TBL] [Abstract][Full Text] [Related]
15. Ultrastructural characterization of the optic pathway in a mouse model of neurofibromatosis-1 optic glioma. Kim KY; Ju WK; Hegedus B; Gutmann DH; Ellisman MH Neuroscience; 2010 Sep; 170(1):178-88. PubMed ID: 20600672 [TBL] [Abstract][Full Text] [Related]